At the news
? BULLISHIMPACT 7/10 6-K filed Mar 26, 2026 at 07:00 ET
Kamada Ltd. announced FDA approval of its plasma collection center in San Antonio, Texas, enabling the facility to commence commercial sales of normal source plasma. The center has an annual collection capacity of approximately 50,000 liters and is expected to generate $8 million to $10 million in annual revenue at full capacity, supporting both normal and specialty plasma collection.
- FDA has approved Kamada's plasma collection center in San Antonio, Texas.
- The facility has a planned annual collection capacity of ~50,000 liters of plasma.
- Estimated annual revenue contribution of $8 million to $10 million at full capacity from normal source plasma sales.
- San Antonio center is anticipated to be one of the largest specialty plasma collection centers in the U.S.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access